Year: 2019. The FDA Adverse Event Reporting System (FAERS) registered 24 drug adverse reports.
|
| Month |
Report ID(s) |
Medicinal Product(s) |
Generic Name(s) |
Brand Name(s) |
Product NDC(s) |
Package NDC(s) |
| 03 |
|
- REMIFENTANIL (CHLORHYDRATE DE)
- REMIFENTANIL HYDROCHLORIDE.
- REMIFENTANIL/REMIFENTANIL HYDROCHLORIDE
- ULTIVA
|
- REMIFENTANIL HYDROCHLORIDE
|
- REMIFENTANIL HYDROCHLORIDE
- ULTIVA
|
- 63323-723
- 63323-724
- 63323-725
- 67457-198
|
|
| 02 |
|
- REMIFENTANIL HYDROCHLORIDE.
- ULTIVA
|
- REMIFENTANIL HYDROCHLORIDE
|
- REMIFENTANIL HYDROCHLORIDE
- ULTIVA
|
- 63323-723
- 63323-724
- 63323-725
- 67457-198
|
|
| 01 |
|
- REDORMIN [REMIFENTANIL HYDROCHLORIDE]
- REMIFENTANIL HCL
- REMIFENTANIL HYDROCHLORIDE.
|
- REMIFENTANIL HYDROCHLORIDE
|
- REMIFENTANIL HYDROCHLORIDE
- ULTIVA
|
- 63323-723
- 63323-724
- 63323-725
- 67457-198
|
|